The correlation between CD200 expression and oxidant-antioxidant status in newly diagnosed B-chronic lymphocytic leukemia patients

Hiba Muwafaq Saleem; Muthanna Mohammed Awad; Alaa Fadhil Alwan

doi:10.53730/ijhs.v6nS9.12163

Authors

Hiba Muwafaq Saleem
h.m.saleem@uoa.edu.iq
Department of Biology, College Sciences, University Of Anbar, Ramadi, Iraq
Muthanna Mohammed Awad Department of Biology, College of Education for Pure Sciences, University Of Anbar, Ramadi, Iraq
Alaa Fadhil Alwan Department of clinical Hematology, The National center of Hematology, Mustansiriyah University, Baghdad, Iraq

Keywords:

CD200, Clinical profile, Oxidant- antioxidant

Abstract

B cell chronic lymphocytic leukemia (B-CLL) is the highest incidence of lymphoproliferative malignant disease in most adults in the western world. Due to the importance of the pathogenicity and risk factors of this disease, this study was designed to analyze the expression the pattern of CD200 by flow cytometer immunophenotyping (FCI) and the association between this marker and some clinical features and oxidant-antioxidant status in B-chronic lymphocytic leukemia patients. This study was conducted on 60 newly diagnostic patients with B-CLL and 30 apparently healthy individuals as control group. The socio-demographic information including (age and sex) and clinical data were also collected in period 20 February 2021 to 25 December. The result of statistical analysis of the present study showed that out of the 60 patients, 39 were male and 21 females, with 30 controls (12 males and 18 females). The mean age of adults patients was (64.04 ± 5.6) years, and the adults control mean age of (63.33 ± 4.70) years therefore, there was a higher prevalence p value ≤0.05 of newly diagnosed CLL patients in males (65.0 %) in compared with females (35.0 %).

Downloads

Download data is not yet available.

References

El-Sharkawy, E. A., Sayed, D. M., Abdel Hamid, W. M., Moness, H., & Yusuf, S. M. (2022). Demographic data in patients with Chronic Lymphocytic Leukemia. Minia Journal of Medical Research, 260-261.‏

Hallek, M., Cheson, B. D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., ... & Kipps, T. J. (2008). Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines. Blood, The Journal of the American Society of Hematology, 111(12), 5446-5456

Quinquenel, A., Aurran-Schleinitz, T., Clavert, A., Cymbalista, F., Dartigeas, C., Davi, F., ... & Troussard, X. (2020). Diagnosis and treatment of chronic lymphocytic leukemia: recommendations of the French CLL Study Group (FILO). Hemasphere, 4(5).‏

Rai, K. R., Sawitsky, A., Cronkite, E. P., Chanana, A. D., Levy, R. N., & Pasternack, B. S. (1975). Clinical staging of chronic lymphocytic leukemia.‏

Binet, J. L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., ... & Gremy, F. (1981). A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 48(1), 198-206.‏

D’Arena, G., De Feo, V., Pietrantuono, G., Seneca, E., Mansueto, G., Villani, O., ... & Laurenti, L. (2020). CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance. Frontiers in Oncology, 10, 2611.‏

Staub, R. B., Marcondes, N. A., & Rotta, L. N. (2021). CD200 expression in hematopoietic neoplasms: Beyond a marker for diagnosis of B-cell neoplasms. Critical Reviews in Oncology/Hematology, 167, 103509.‏

Kotwica-Mojzych, K., Jodłowska-Jędrych, B., & Mojzych, M. (2021). CD200: CD200R interactions and their importance in immunoregulation. International Journal of Molecular Sciences, 22(4), 1602.‏

Ames, B. N., & Gold, L. S. (2000). Paracelsus to parascience: the environmental cancer distraction. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 447(1), 3-13.‏

Eckl, P. M., & Bresgen, N. (2017). Genotoxicity of lipid oxidation compounds. Free radical biology and medicine, 111, 244-252.‏

Leone, A., Roca, M. S., Ciardiello, C., Costantini, S., & Budillon, A. (2017). Oxidative stress gene expression profile correlates with cancer patient poor prognosis: identification of crucial pathways might select novel therapeutic approaches. Oxidative Medicine and Cellular Longevity, 2017.‏

Sies, H. (2020). Oxidative stress: Concept and some practical aspects. Antioxidants, 9(9), 852.‏

Hileman, E. A., Achanta, G., & Huang, P. (2001). Superoxide dismutase: an emerging target for cancer therapeutics. Expert Opinion on Therapeutic Targets, 5(6), 697-710.‏

Zhevak, T., Shelekhova, T., Chesnokova, N., Tsareva, O., Chanturidze, A., Litvitsky, P., ... & Budnik, I. (2020). The relationship between oxidative stress and cytogenetic abnormalities in B-cell chronic lymphocytic leukemia. Experimental and Molecular Pathology, 116, 104524.‏

Jakšić, B., Vitale, B., Hauptmann, E., Planinc-Peraica, A., Ostojic, S., & Kusec, R. (1991). The roles of age and sex in the prognosis of chronic leukaemias. A study of 373 cases. British journal of cancer, 64(2), 345-348.

Yamamoto, J. F., & Goodman, M. T. (2008). Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002. Cancer Causes & Control, 19(4), 379-390

Porter, R. S., & Kaplan, J. L. (2011). The Merck Manual of Diagnosis and Therapy Nineteenth Edition. Merck sharp & Dohme corp., A subsidiary of Merck & Co. Inc., Whithouse station, 2868.

Zwiebel, J. A., & Cheson, B. D. (1998, February). Chronic lymphocytic leukemia: staging and prognostic factors. In Seminars in oncology (Vol. 25, No. 1, pp. 42-59).‏

Nagieb, R. M., El-Ashmawy, H. E. S. A., Hashim, A. M., & Bakry, R. (2022). Role of immunophenotyping in diagnosis of CLL patient at South Egypt Cancer Institute. Minia Journal of Medical Research, 71-76.‏

Rawstron, A. C., Kreuzer, K. A., Soosapilla, A., Spacek, M., Stehlikova, O., Gambell, P., ... & Montserrat, E. (2018). Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project. Cytometry Part B: Clinical Cytometry, 94(1), 121-128.‏

Urbaniak, M., Iskierka-Jażdżewska, E., Majchrzak, A., & Robak, T. (2022). Atypical immunophenotype of chronic lymphocytic leukemia. Acta Haematologica Polonica, 53(1), 48-52.‏

Hamad, H. M., Shabeeb, Z. A., & Awad, M. M. (2022). Expressions of CD274 (PD-L1) and CD47 rReceptors on the sSurface of bBlast cCells in AML pPatients. Iraqi Journal of Science, 2373-2387.‏

Srisurapanont, K., Thepchinda, T., Kasirawat, C., & Rattanathammethee, T. (2020). Prognostic Role of CD200 Expression in Hematologic Malignancies: A Systematic Review and Meta-Analysis. Available at SSRN 3559591.‏

Zahedi, M., Khorasani, S. S. K., Nasirzadeh, A., Abouali, R., Abounoori, M., Mortazavi, P., ... & Mohseni, A. R. (2019). Promising Role of CD200 Expression in Diagnosis and Prognosis of Chronic Lymphocytic Leukemia: A Review. International Journal of Medical Investigation, 8(4), 16-22.‏

Miguet, L., Mayeur-Rousse, C., Eischen, A., Galoisy, A. C., Rolland, D. C., Gervais, C., ... & Mauvieux, L. (2021). The Contribution of CD148, CD180 and CD200 Combination in the Diagnosis of Chronic B-Cell Lymphoproliferative Disorders. Blood, 138, 3520.‏ El Desoukey, N. A., Afify, R. A. A., Amin, D. G., & Mohammed, R. F. (2012). CD200 expression in B-cell chronic lymphoproliferative disorders. Journal of investigative medicine, 60(1), 56-61.‏

Wang, X., Zhang, Z., Liu, Y., Wang, L., Yuan, H., Xie, P., & Qu, J. (2014). Expression of CD200 in the bone marrow of chronic lymphocytic leukemia patients and its correlations with clinical prognosis. Xi bao yu fen zi mian yi xue za zhi= Chinese journal of cellular and molecular immunology, 30(1), 75-78.‏

Rahman, K., Kumar, P., Gupta, R., Singh, M. K., & Nityanand, S. (2017). Role of CD 200 in differential diagnosis of mature B‐cell neoplasm. International journal of laboratory hematology, 39(4), 384-391.‏

Divya, P., Vangala, N., Uppin, M. S., Uppin, S. G., Gundeti, S., Bacchu, S., ... & Paul, T. R. (2022). Utility of CD200 expression by flow cytometry in lymphoproliferative disorders and plasma cell dyscrasias.‏

Fouad, N. B. E. D., Ibrahim, N. Y., Aziz, R. S. A., & Ibrahim, S. K. (2018). CD200 expression in diagnostic and prognostic assessment of mature B cell lymphophoproliferative neoplasms. Asian Pacific journal of cancer prevention: APJCP, 19(12), 3383.‏

Baraka, A., & Salem, H. M. (2012). Study of CD200 in chronic lymphocytic leukemia. The Egyptian Journal of Haematology, 37(2), 111.‏

De Santis, M. C., Porporato, P. E., Martini, M., & Morandi, A. (2018). Signaling pathways regulating redox balance in cancer metabolism. Fro [30]D'arena, G., Vitale, C., Perbellini, O., Coscia, M., La Rocca, F., Ruggieri, V., ... & Iorio, E. L. (2017). Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia. European journal of haematology, 99(4), 306-314.‏

Zhevak, T., Shelekhova, T., Chesnokova, N., Tsareva, O., Chanturidze, A., Litvitsky, P., ... & Budnik, I. (2020). The relationship between oxidative stress and cytogenetic abnormalities in B-cell chronic lymphocytic leukemia. Experimental and Molecular Pathology, 116, 104524.‏

Bakan, N., Taysi, S., Yilmaz, Ö., Bakan, E., Kuşkay, S., Uzun, N., & Gündoğdu, M. (2003). Glutathione peroxidase, glutathione reductase, Cu–Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia. Clinica Chimica Acta, 338(1-2), 143-149.‏

Oltra, A. M., Carbonell, F., Tormos, C., Iradi, A., & Sáez, G. T. (2001). Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic lerkenia. Free Radical Biology and Medicine, 30(11), 1286-1292.‏

Salimi, A., Roudkenar, M. H., Sadeghi, L., Mohseni, A., Seydi, E., Pirahmadi, N., & Pourahmad, J. (2016). Selective anticancer activity of acacetin against chronic lymphocytic leukemia using both in vivo and in vitro methods: key role of oxidative stress and cancerous mitochondria. Nutrition and cancer, 68(8), 1404-1416.‏

Mehde, A. A., & Yousif, A. M. (2014). Estimation of Malondialdehyde, Total Antioxidant Capacity and Some Biochemical Parameters in CSF and Sera of Patients with Acute Lymphoblastic Leukemia. Australian journal of basic and applied sciences, 8(15), 329-333.‏‏

Mantovani, G., Macciò, A., Madeddu, C., Mura, L., Gramignano, G., Lusso, M. R., ... & Elsener, B. (2002). Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status. International Journal of Cancer, 98(1), 84-91.

D’Arena, G., Seneca, E., Migliaccio, I., De Feo, V., Giudice, A., La Rocca, F., ... & Ruggieri, V. (2019). Oxidative stress in chronic lymphocytic leukemia: still a matter of debate. Leukemia & Lymphoma, 60(4), 867-875.‏

D'arena, G., Vitale, C., Perbellini, O., Coscia, M., La Rocca, F., Ruggieri, V., ... & Iorio, E. L. (2017). Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia. European journal of haematology, 99(4), 306-314.

Gaibullaeva, N. N. (2021). The role of clinical examination early diagnosis of glaucoma. International Journal of Health & Medical Sciences, 4(3), 333-337. https://doi.org/10.31295/ijhms.v4n3.1745

Zhevak, T., Shelekhova, T., Chesnokova, N., Tsareva, O., Chanturidze, A., Litvitsky, P., ... & Budnik, I. (2020). The relationship between oxidative stress and cytogenetic abnormalities in B-cell chronic lymphocytic leukemia. Experimental and Molecular Pathology, 116, 104524.‏

Collado, R., Ivars, D., Oliver, I., Tormos, C., Egea, M., Miguel, A., ... & Carbonell, F. (2014). Increased oxidative damage associated with unfavorable cytogenetic subgroups in chronic lymphocytic leukemia. BioMed Research International, 2014.‏

Zelen, I., Djurdjevic, P., Popovic, S., Stojanovic, M., Jakovljevic, V., Radivojevic, S., ... & Arsenijevic, N. (2010). Antioxidant enzymes activities and plasma levels of oxidative stress markers in B-chronic lymphocytic leukemia patients. J buon, 15(2), 330-336.‏

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949

Hwang, A. B., & Lee, S. J. (2011). Regulation of life span by mitochondrial respiration: the HIF-1 and ROS connection. Aging (Albany NY), 3(3), 304.‏

Kumar, S., Yedjou, C. G., & Tchounwou, P. B. (2014). Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells. Journal of experimental & clinical cancer research, 33(1), 1-12.‏

Gaman, A. M., Buga, A. M., Gaman, M. A., & Popa-Wagner, A. (2014). The role of oxidative stress and the effects of antioxidants on the incidence of infectious complications of chronic lymphocytic leukemia. Oxidative Medicine and Cellular Longevity, 2014.